Back to Rankings

LLY

Eli Lilly andA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
LLY vs peer average
76/100
LLY vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 3 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Scale biotech with strong cash generation and capital returns; a benchmark for how much the market pays for durable growth and pipeline execution.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
LLY
Eli Lilly and
AMGN
Amgen
Grade
A
C
Momentum
83
36
Value
59
64
Sentiment
55
47
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs AMGN

LLY / AMGN
Grade Position
Above peers
LLY vs. peer average (A vs. C)
76/100
Momentum
83
LLY
Value
59
AMGN
Sentiment
55
LLY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LLY
1
AMGN
AMGN
C
60/100
+2
2
ABBV
ABBV
B
80/100
+1
3
JNJ
JNJ
C
60/100
+2
4
MRK
MRK
B
80/100
+1
5
AZN
AZN
F
20/100
+4
AMGN is the first peer returned for this comparison set.